Ada göre bir ilaç arayın

Abilify Discmelt ve Geç diskinezi

Abilify Discmelt ilacının Geç diskinezi hastalığı ile etkileşiminin güvenlik kontrolünün sonucu.

Kontrolün sonucu:

Abilify Discmelt <> Geç diskinezi

Güncellik: 23.07.2019 Eleştirmen: MD PHD P.M. Shkutko, in

Drugs.com, Rxlist.com, Webmd.com, Medscape.com gibi yetkili kaynaklara dayalı kontrolün sonucunda bu ilacın bu komorbid hastalık ile etkileşmesi halinde zarar verebilen veya olumsuz etkisini artırabilen kontrendikasyonlar veya yan etkiler bulundu.

Tüketici:

Nöroleptik ajanlar, değişik dil, yüz, ağız, dudak, çene karıştığı ritmik istemsiz hareketler oluşan bir sendrom ve/veya gövde ve ekstremitelerde (TD) tardif diskinezi belirtileri çökelti, en az birkaç ay kronik yıl sık sık kullanın ama aşağıdaki olabilir. Yaşlı hastalar, özellikle kadınlar, en çok hassastırlar. Süresi ve uygulanan nöroleptik tedavinin toplam dozu ile geri dönüşü olmayan bir artış olacak hem de sendromu oluşma riski o kadar yüksektir. Ancak, hastalar nadiren düşük dozlarda nispeten kısa tedavi süreleri sonra belirtiler gelişebilir. Eğer TD nöroleptik tedavi, soruna neden olan ajan derhal geri çekilmesi sırasında oluşursa veya doz azaltılması, en azından kabul edilmelidir. TD semptomlar ilacın kesilmesi veya doz azaltma sonra daha şiddetli olabilir, ama yavaş yavaş yıl için ayda artırabilir. Uyuşturucu kaynaklı TD önceden başlatılması veya nöroleptik tedavi dozu geçici olarak TD belirtileri maskeleyebilir artan ama sonunda olan hastalarda durumu kötüleştirebilir. (Örneğin, risperidon, klozapin, insan) daha yeni, atipik nöroleptik ajanlar TD oluşması oldukça düşük bir risk ile ilişkili olma eğilimindedir ve psikoz tedavisi gören hastalarda tercih edilen ilaç olarak kabul edilir.

Kaynaklar

Pinder RM, Brogden RN, Swayer R, Speight TM, Spencer R, Avery GS "Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry." Drugs 12 (1976): 1-40
Yesavage JA, Tanke ED, Sheikh JI "Tardive dyskinesia and steady-state serum levels of thiothixene." Arch Gen Psychiatry 44 (1987): 913-5
"Product Information. Risperdal (risperidone)." Janssen Pharmaceutica, Titusville, NJ.
Ghelber D, Belmaker RH "Tardive dyskinesia with quetiapine." Am J Psychiat 156 (1999): 796-7
"Product Information. Abilify (aripiprazole)." Bristol-Myers Squibb, Princeton, NJ.
Little JT, Jankovic J "Tardive myoclonus." Mov Disord 2 (1987): 307-11
"Product Information. Orap Tablets (pimozide)." Gate Pharmaceuticals, Sellersville, PA.
"Product Information. Zyprexa (olanzapine)." Lilly, Eli and Company, Indianapolis, IN.
"Product Information. Geodon (ziprasidone)." Pfizer US Pharmaceuticals, New York, NY.
Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao XM "Clozapine in tardive dyskinesia - observations from human and animal model studies." J Clin Psychiatry 55 (1994): 102-6
Yassa R, Mohelsky HE "Tardive dyskinesia in thiothixene treatment ." J Clin Psychiatry 46 (1985): 151
"Product Information. Navane (thiothixene)." Roerig Division, New York, NY.
Branchey MH, Branchey LB, Richardson MA "Effects of neuroleptic adjustment on clinical condition and tardive dyskinesia in schizophrenic patients." Am J Psychiatry 138 (1981): 608-12
de Leon J, Moral L, Camunas C "Clozapine and jaw dyskinesia: a case report." J Clin Psychiatry 52 (1991): 494-5
Pakkenberg H, Fog R "Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both." Arch Neurol 31 (1974): 352-3
Gwinn KA, Caviness JN "Risperidone-induced tardive dyskinesia and parkinsonism." Mov Disord 12 (1997): 119-21
Meltzer HY, Luchins DJ "Effect of clozapine in severe tardive dyskinesia: a case report." J Clin Psychopharmacol 4 (1984): 286-7
Bransgrove LL, Kelly MW "Movement disorders in patients treated with long-acting injectable antipsychotic drugs." Am J Hosp Pharm 51 (1994): 895-9
Elliott ES, Marken PA, Ruehter VL "Clozapine-associated extrapyramidal reaction." Ann Pharmacother 34 (2000): 615-8
Friedman JH "Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases." Mov Disord 9 (1994): 321-4
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM "Pharmacotherapy: A Pathophysiologic Approach 4th" Stamford, CT: Appleton & Lange (1999):
Narendran R, Young CM, Pato MT "Possible risperidone-induced tardive dystonia." Ann Pharmacother 34 (2000): 1487-8
Peabody CA, Brody D, Warner MD "Tardive dyskinesia after low-dose haloperidol." Biol Psychiatry 22 (1987): 111-2
"Product Information. Haldol (haloperidol)." McNeil Pharmaceutical, Raritan, NJ.
Lamberti JS, Bellnier T "Clozapine and tardive dystonia." J Nerv Ment Dis 181 (1993): 137-8
"Product Information. Loxitane C Oral Concentrate (loxapine)" Watson Laboratories Inc, Corona, CA.
"Product Information. Seroquel (quetiapine)." Zeneca Pharmaceuticals, Wilmington, DE.
Riddle MA, Hardin MT, Towbin KE, et al "Tardive dyskinesia following haloperidol treatment in Tourette's syndrome." Arch Gen Psychiatry 44 (1987): 98-9
Dave M "Tardive oculogyric crises with clozapine." J Clin Psychiatry 55 (1994): 264-5
"Product Information. Clozaril (clozapine)." Novartis Pharmaceuticals, East Hanover, NJ.
Heel RC, Brogden RN, Speight TM, Avery GS "Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent." Drugs 15 (1978): 198-217
Kopala LC, Honer WG "Schizophrenia and severe tardive dyskinesia responsive to risperidone." J Clin Psychopharmacol 14 (1994): 430-1
Buzan RD "Risperidone-induced tardive dyskinesia." Am J Psychiatry 153 (1996): 734-5
Dave M "Clozapine-related tardive dyskinesia." Biol Psychiatry 35 (1994): 886-7
"Product Information. Moban (molindone)." Gate Pharmaceuticals, Sellersville, PA.
Bruun RD "Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder." Am J Psychiatry 145 (1988): 621-4
Portnoy RA "Hyperkinetic dysarthria as an early indicator of impending tardive dyskinesia." J Speech Hear Disord 44 (1979): 214-9
Mahmood T, Clothier EB, Bridgman R "Risperidone-induced extrapyramidal reactions." Lancet 346 (1995): 1226
Herran A, Vazquez-Barquero JL "Tardive dyskinesia associated with olanzapine." Ann Intern Med 131 (1999): 72
Woerner MG, Sheitman BB, Lieberman JA, Kane JM "Tardive dyskinesia induced by risperidone?" Am J Psychiatry 153 (1996): 843
Owens DGC "Extrapyramidal side effects and tolerability of risperidone - a review." J Clin Psychiatry 55 Suppl (1994): 29-35
Small JG, Milstein V, Marhenke JD, Hall DD, Kellams JJ "Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis." J Clin Psychiatry 48 (1987): 263-7